NCT01629589View on ClinicalTrials.gov

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions
TetanusDiphtheriaPertussisWhooping Cough
Interventions
BIOLOGICAL

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®)

0.5 mL, Intramuscular

BIOLOGICAL

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®)

0.5 mL, Intramuscular

Trial Locations (8)

22180

Vienna

29812

Barnwell

37660

Kingsport

40040

Bardstown

44121

Cleveland

84124

Salt Lake City

95816

Sacramento

07801

Woburn

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01629589 - Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents | Biotech Hunter | Biotech Hunter